TAM
VKTX icon

Tocqueville Asset Management’s Viking Therapeutics VKTX Stock Holding History

Tocqueville Asset Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,230
Closed -$814K – 557
2024
Q4 		$814K Buy
+20,230
New +$1.15M 0.01% 377
2019
Q4 		– Sell
-25,275
Closed -$174K – 771
2019
Q3 		$174K Sell
25,275
-9,475
-27% -$70.4K ﹤0.01% 729
2019
Q2 		$288K Sell
34,750
-23,125
-40% -$198K ﹤0.01% 689
2019
Q1 		$575K Buy
57,875
+16,300
+39% +$136K 0.01% 563
2018
Q4 		$318K Sell
41,575
-2,825
-6% -$33.8K ﹤0.01% 622
2018
Q3 		$773K Buy
+44,400
New +$528K 0.01% 540

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return